Patents by Inventor Catherine Killion

Catherine Killion has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20010051374
    Abstract: A method is provided for producing a population of genetically modified T cells. In the method, an in vitro population of T cells is activated by contacting said population with a CD3 binding agent. Genetic modification is then carried out with the activated T cells by contacting the same with a suitable gene transfer vector.
    Type: Application
    Filed: December 3, 1999
    Publication date: December 13, 2001
    Inventors: ELIZABETH MCLAUGHLIN-TAYLOR, MARK KRUGER, CHERYL LUNDAK, CATHERINE KILLION
  • Patent number: 6114113
    Abstract: A method is provided for producing a population of genetically modified T cells. In the method, an in vitro population of T cells is activated by contacting said population with a CD3 binding agent. Genetic modification is then carried out with the activated T cells by contacting the same with a suitable gene transfer vector.
    Type: Grant
    Filed: August 11, 1998
    Date of Patent: September 5, 2000
    Assignee: Chiron Corporation
    Inventors: Elizabeth McLaughlin-Taylor, Mark Kruger, Cheryl Lundak, Catherine Killion